| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.39B | -0.8% |
| Cost of Revenue | $8.46B | -2.2% |
| Gross Profit | $1.93B | +5.8% |
| R&D Expense | $398.0M | -6.4% |
| SG&A Expense | $530.0M | +6.4% |
| Operating Income | $979.0M | +41.9% |
| Interest Expense | $108.0M | +16.1% |
| Pre-tax Income | $875.0M | +43.0% |
| Income Tax | $227.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $330.0M | -33.7% |
| Accounts Receivable | $1.99B | -9.3% |
| Inventory | $921.0M | -9.0% |
| Current Assets | $3.48B | -12.4% |
| Total Assets | $7.80B | -6.3% |
| Current Liabilities | $3.63B | -10.0% |
| Long-term Debt | $1.52B | +15.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.06B | +7.8% |
| Capital Expenditures | $579.0M | +1.0% |
| Investing Cash Flow | -$563.0M | +1.1% |
| Financing Cash Flow | -$680.0M | -38.8% |
| Free Cash Flow | $480.0M | +17.4% |
| +84.6% |
| Net Income | $646.0M | +32.4% |
| EPS (Basic) | $8.06 | +40.4% |
| EPS (Diluted) | $8.04 | +40.6% |
| Stockholders' Equity |
| $2.28B |
| -11.0% |